Cargando…
YiQiFuMai injection for chronic heart failure: Protocol for a systematic review and meta-analysis
BACKGROUND: Chronic heart AQ4 failure (CHF) is the final stage of various heart diseases. YiQiFuMai injection (YQFMI) has been widely applied in the treatment of CHF. However, to our knowledge, there has been no systematic review or meta-analysis of randomized controlled trails (RCTs) regarding the...
Autores principales: | Wang, Yuanping, Li, Xiaohui, Li, Ziqing, Zhang, Yu, Wang, Dawei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5842014/ https://www.ncbi.nlm.nih.gov/pubmed/29465586 http://dx.doi.org/10.1097/MD.0000000000009957 |
Ejemplares similares
-
The chemical components, action mechanisms, and clinical evidences of YiQiFuMai injection in the treatment of heart failure
por: Lv, Shichao, et al.
Publicado: (2022) -
Injection of YiQiFuMai powder protects against heart failure via inhibiting p38 and ERK1/2 MAPKs activation
por: Nie, Yongwei, et al.
Publicado: (2022) -
YiQiFuMai Powder Injection Ameliorates Cerebral Ischemia by Inhibiting Endoplasmic Reticulum Stress-Mediated Neuronal Apoptosis
por: Cao, Guosheng, et al.
Publicado: (2016) -
YiQiFuMai powder injection ameliorates blood–brain barrier dysfunction and brain edema after focal cerebral ischemia–reperfusion injury in mice
por: Cao, Guosheng, et al.
Publicado: (2016) -
YiQiFuMai Powder Injection Attenuates Coronary Artery Ligation-Induced Heart Failure Through Improving Mitochondrial Function via Regulating ROS Generation and CaMKII Signaling Pathways
por: Zhang, Yu, et al.
Publicado: (2019)